A Novel, Structured Fellow Training Pathway for Robotic-Assisted Sacrocolpopexy.


Journal

The Permanente journal
ISSN: 1552-5775
Titre abrégé: Perm J
Pays: United States
ID NLM: 9800474

Informations de publication

Date de publication:
26 05 2021
Historique:
received: 20 08 2020
accepted: 03 02 2021
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 5 4 2022
Statut: epublish

Résumé

We developed a novel fellow education pathway for robotic-assisted sacrocolpopexy (RASC) and aimed to compare step-specific and total operative times for RASC performed by Female Pelvic Medicine and Reconstructive Surgery (FPMRS) attendings with those in which FPMRS fellows performed part or all of the RASC. We further aimed to compare complication and readmission rates by fellow involvement. We tracked RASC at 1 institution between 2012 and 2018. We recorded times for total procedure, sacrocolpopexy, and 6 individual steps. Fellows were designated F1-F3 by training year. We used independent samples t-tests and analysis of variance for continuous variables and χ Of 178 RASC procedures, 76 (42.7%) involved fellows. Concomitant procedures included hysterectomy (62.4%), midurethral sling (50%), and colporrhaphy/perineorrhaphy (51.7%). RASC without and with fellows had similar demographic, clinical, and procedural characteristics, except for midurethral sling rate (attending, 42.2% vs fellow, 60.5%; p = 0.02). RASC without and with fellows had similar times for total procedure (208.9 ± 61.0 vs 209.1 ± 48.6 minutes, p = 0.98), sacrocolpopexy (116.9 ± 39.9 vs 122.7 ± 29.2 minutes, p = 0.27), and all RASC steps except docking (attendings, 9.9 ± 8.6 vs fellows, 7.2 ± 7.0 minutes; p = 0.03). Complication rates and severity were similar without and with fellows. There were no readmissions. Our novel structured training program provides safe limitations for total and step-specific procedural times during fellowship education in RASC. Such training programs warrant further study to determine potential contribution to quality and safety in the teaching environment.

Identifiants

pubmed: 35348059
doi: 10.7812/TPP/20.224
pmc: PMC8817941
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Eur Urol. 2014 Jun;65(6):1128-37
pubmed: 24433811
J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):1049-58
pubmed: 26070725
Eur Urol. 2016 Mar;69(3):526-35
pubmed: 26585582
Female Pelvic Med Reconstr Surg. 2011 Jan;17(1):44-9
pubmed: 22453672
Am J Surg. 2002 Jun;183(6):702-7
pubmed: 12095605
Obstet Gynecol. 2014 Jan;123(1):5-12
pubmed: 24463657
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Female Pelvic Med Reconstr Surg. 2014 Sep-Oct;20(5):252-60
pubmed: 25181374
Urology. 2002 Jul;60(1):39-45; discussion 45
pubmed: 12100918
World J Urol. 2017 Jan;35(1):27-34
pubmed: 27106491
Int J Gynaecol Obstet. 2016 Mar;132(3):284-91
pubmed: 26797199
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Cochrane Database Syst Rev. 2016 Oct 01;10:CD012376
pubmed: 27696355
Surg Endosc. 2007 Jun;21(6):912-5
pubmed: 17177085
Obstet Gynecol. 2011 Nov;118(5):1005-1013
pubmed: 21979458
J Urol. 2011 Apr;185(4):1191-7
pubmed: 21334030
Int Urogynecol J. 2018 Sep;29(9):1317-1323
pubmed: 28889173
Surgery. 2010 Jun;147(6):830-9
pubmed: 20045162
Am J Obstet Gynecol. 2005 May;192(5):1752-8
pubmed: 15902189
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
J Endourol. 2007 Aug;21(8):926-30
pubmed: 17867956
Surg Endosc. 2009 Oct;23(10):2390-4
pubmed: 19172354
Gynecol Surg. 2016;13:115-123
pubmed: 27226787
Int Urogynecol J. 2016 Feb;27(2):239-46
pubmed: 26294206
Int Urogynecol J. 2018 Oct;29(10):1537-1542
pubmed: 29464301
Surg Endosc. 2008 Feb;22(2):313-25; discussion 311-2
pubmed: 18163170
Int J Surg. 2015 Jan;13:115-123
pubmed: 25486264
Int Urogynecol J. 2013 Mar;24(3):377-84
pubmed: 22864764
Int Urogynecol J. 2013 Nov;24(11):1893-7
pubmed: 23640003

Auteurs

Tatiana Catanzarite (T)

Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Southern California Permanente Medical Group, San Diego, CA.

Jasmine Tan-Kim (J)

Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Southern California Permanente Medical Group, San Diego, CA.

John N Nguyen (JN)

Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Southern California Permanente Medical Group, Downey, CA.

Sharon Jakus-Waldman (S)

Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Southern California Permanente Medical Group, Downey, CA.

Shawn A Menefee (SA)

Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Southern California Permanente Medical Group, San Diego, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH